Sands Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $269M | Sell |
|
|||||
|
2018
Q3 | $412M | Sell |
|
|||||
|
2018
Q2 | $400M | Sell |
|
|||||
|
2018
Q1 | $384M | Sell |
|
|||||
|
2017
Q4 | $545M | Sell |
|
|||||
|
2017
Q3 | $670M | Sell |
|
|||||
|
2017
Q2 | $772M | Buy |
|
|||||
|
2017
Q1 | $635M | Sell |
|
|||||
|
2016
Q4 | $683M | Buy |
|
|||||
|
2016
Q3 | $643M | Buy |
|
|||||
|
2016
Q2 | $569M | Sell |
|
|||||
|
2016
Q1 | $726M | Sell |
|
|||||
|
2015
Q4 | $1.16B | Sell |
|
|||||
|
2015
Q3 | $998M | Sell |
|
|||||
|
2015
Q2 | $1.18B | Buy |
|
|||||
|
2015
Q1 | $902M | Sell |
|
|||||
|
2014
Q4 | $975M | Sell |
|
|||||
|
2014
Q3 | $881M | Buy |
|
|||||
|
2014
Q2 | $825M | Buy |
|
|||||
|
2014
Q1 | $801M | Sell |
|
|||||
|
2013
Q4 | $979M | Sell |
|
|||||
|
2013
Q3 | $876M | Sell |
|
|||||
|
2013
Q2 | $777M | Buy |
|